164 related articles for article (PubMed ID: 24590453)
1. The population impact of familial cancer, a major cause of cancer.
Frank C; Fallah M; Ji J; Sundquist J; Hemminki K
Int J Cancer; 2014 Apr; 134(8):1899-906. PubMed ID: 24590453
[TBL] [Abstract][Full Text] [Related]
2. Attributable risks for familial breast cancer by proband status and morphology: a nationwide epidemiologic study from Sweden.
Hemminki K; Granström C; Czene K
Int J Cancer; 2002 Jul; 100(2):214-9. PubMed ID: 12115572
[TBL] [Abstract][Full Text] [Related]
3. Attributable risks of familial cancer from the Family-Cancer Database.
Hemminki K; Czene K
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1638-44. PubMed ID: 12496055
[TBL] [Abstract][Full Text] [Related]
4. Familial risk of cancer shortly after diagnosis of the first familial tumor.
Bermejo JL; Hemminki K
J Natl Cancer Inst; 2005 Nov; 97(21):1575-9. PubMed ID: 16264177
[TBL] [Abstract][Full Text] [Related]
5. Age specific and attributable risks of familial prostate carcinoma from the family-cancer database.
Hemminki K; Czene K
Cancer; 2002 Sep; 95(6):1346-53. PubMed ID: 12216104
[TBL] [Abstract][Full Text] [Related]
6. Contribution of shared environmental factors to familial aggregation of common cancers: an adoption study in Sweden.
Sundquist K; Sundquist J; Ji J
Eur J Cancer Prev; 2015 Mar; 24(2):162-4. PubMed ID: 25415834
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers.
Leu M; Reilly M; Czene K
J Natl Cancer Inst; 2008 Sep; 100(18):1318-25. PubMed ID: 18780865
[TBL] [Abstract][Full Text] [Related]
8. Concordant and discordant familial cancer: Familial risks, proportions and population impact.
Frank C; Sundquist J; Yu H; Hemminki A; Hemminki K
Int J Cancer; 2017 Apr; 140(7):1510-1516. PubMed ID: 28006863
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
10. Risk for contralateral breast cancers in a population covered by mammography: effects of family history, age at diagnosis and histology.
Ji J; Hemminki K
Breast Cancer Res Treat; 2007 Oct; 105(2):229-36. PubMed ID: 17115107
[TBL] [Abstract][Full Text] [Related]
11. Risk of prostate, breast and colorectal cancer after skin cancer diagnosis.
Levi F; Randimbison L; Te VC; Conconi MM; La Vecchia C
Int J Cancer; 2008 Dec; 123(12):2899-901. PubMed ID: 18770862
[TBL] [Abstract][Full Text] [Related]
12. Familial transmission of prostate, breast and colorectal cancer in adoptees is related to cancer in biological but not in adoptive parents: a nationwide family study.
Zöller B; Li X; Sundquist J; Sundquist K
Eur J Cancer; 2014 Sep; 50(13):2319-27. PubMed ID: 24953336
[TBL] [Abstract][Full Text] [Related]
13. Familial and second primary pancreatic cancers: a nationwide epidemiologic study from Sweden.
Hemminki K; Li X
Int J Cancer; 2003 Feb; 103(4):525-30. PubMed ID: 12478670
[TBL] [Abstract][Full Text] [Related]
14. Familial risks in in situ cancers from the Family-Cancer Database.
Hemminki K; Vaittinen P
Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):865-8. PubMed ID: 9796630
[TBL] [Abstract][Full Text] [Related]
15. Multiple primary cancers of the colon, breast and skin (melanoma) as models for polygenic cancers.
Dong C; Hemminki K
Int J Cancer; 2001 Jun; 92(6):883-7. PubMed ID: 11351311
[TBL] [Abstract][Full Text] [Related]
16. Age- and time-dependent changes in cancer incidence among immigrants to Sweden: colorectal, lung, breast and prostate cancers.
Mousavi SM; Fallah M; Sundquist K; Hemminki K
Int J Cancer; 2012 Jul; 131(2):E122-8. PubMed ID: 22052616
[TBL] [Abstract][Full Text] [Related]
17. The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015.
Brown KF; Rumgay H; Dunlop C; Ryan M; Quartly F; Cox A; Deas A; Elliss-Brookes L; Gavin A; Hounsome L; Huws D; Ormiston-Smith N; Shelton J; White C; Parkin DM
Br J Cancer; 2018 Apr; 118(8):1130-1141. PubMed ID: 29567982
[TBL] [Abstract][Full Text] [Related]
18. Risk of incident and fatal melanoma in individuals with a family history of incident or fatal melanoma or any cancer.
Brandt A; Sundquist J; Hemminki K
Br J Dermatol; 2011 Aug; 165(2):342-8. PubMed ID: 21457213
[TBL] [Abstract][Full Text] [Related]
19. Multiple primary (even in situ) melanomas in a patient pose significant risk to family members.
Chen T; Hemminki K; Kharazmi E; Ji J; Sundquist K; Fallah M
Eur J Cancer; 2014 Oct; 50(15):2659-67. PubMed ID: 25103454
[TBL] [Abstract][Full Text] [Related]
20. Familial risks of breast and prostate cancers: does the definition of the at risk period matter?
Brandt A; Bermejo JL; Sundquist J; Hemminki K
Eur J Cancer; 2010 Mar; 46(4):752-7. PubMed ID: 20022238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
